Month: <span>July 2017</span>

Home / 2017 / July
Post

New Microfluidic Chip Detects Circulating Tumor Cells in Real Time

At the Rovira i Virgili University in Catalan, Spain, researchers have developed and patented a microfluidic device for detecting circulating tumor cells within whole blood that originate from breast cancer tumors and which are responsible for metastasis.  The device, reported on in journal Scientific Reports, and already tested on blood of breast cancer patients at different stages...

Post

Hemopurifier Filters Ebola, Hep C, Metastatic Melanoma: Interview with James A. Joyce, CEO of Aethlon Medical

Filtering infectious pathogens and cancer cells directly from whole blood has been an almost fantastic proposition, but the Hemopurifier from Aethlon Medical does just that. We’ve been covering it for over 10 years on Medgadget as it proves itself in clinical trials and new applications for it are discovered. It has already been studied as a treatment...

Post

Breaking the genetic resistance of lung cancer and melanoma

Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance to targeted therapies. Dr Luciano Martelotto, from the Monash University Faculty of Medicine, and his collaborators Dr Piro Lito and Yaohua Xue...

Post

Partnering cells turn off immune attack on pancreatic tumors

Two cell types work together to protect pancreatic tumors from destruction by the immune system. But, blocking this partnership may restore the system’s ability to attack these same tumor cells. These are the findings of a study in mice led by researchers from NYU Langone Medical Center and its Perlmutter Cancer Center, and published online...

Post

New way found to boost immunity in fight cancer and infections

An international research team led by Université de Montréal medical professor Christopher Rudd, director of research in immunology and cell therapy at Maisonneuve-Rosemont Hospital Research Centre, has identified a key new mechanism that regulates the ability of T-cells of the immune system to react against foreign antigens and cancer. T-cells orchestrate the response of the...

Post

What makes stem cells into perfect allrounders

Stem cells are considered biological allrounders because they have the potential to develop into the various body cell types. For the majority of stem cells, however, this designation is too far-reaching. Adult stem cells, for example, can replace cells in their own tissue in case of injury, but a fat stem cell will never generate...

Post

Lab-grown human colons change study of GI disease

Scientists used human pluripotent stem cells to generate human embryonic colons in a laboratory that function much like natural human tissues when transplanted into mice, according to research published June 22 in Cell Stem Cell. The study is believed to be the first time human colon organoids have been successfully tissue engineered in this manner, according...

Post

One Gene Closer to Regenerative Therapy for Muscular Disorders

A detour on the road to regenerative medicine for people with muscular disorders is figuring out how to coax muscle stem cells to fuse together and form functioning skeletal muscle tissues. A study published June 1, by Nature Communications reports scientists identify a new gene essential to this process, shedding new light on possible new therapeutic strategies....

Post

Reducing inflammation protects stem cells during wound repair

Scientists have found a new way to protect stem cells from harsh inflammation during wound repair. In a study recently published in the journal Cytotherapy, researchers in India discovered that treating mice with a common anti-inflammatory drug called celecoxib promoted stem cell survival and healing when they injected the cells into wounds. The researchers, who are...